@Jennifer-Carroll Thanks very much! One last question about these email templates: do they have to bear the PAAB logo on the emails themselves, or is it sufficient that the attached APSs have the logo displayed?
E
Einstein
@Einstein
The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB),
including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB
correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system.
Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly
prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.
Posts
-
Clarification regarding digitization of APS: Helping healthcare product manufacturers plan for the evolving COVID-19 operational context. -
Clarification regarding digitization of APS: Helping healthcare product manufacturers plan for the evolving COVID-19 operational context.@Jennifer-Carroll With regards to naming conventions, are we required to submit a full, exact list of all PDF names that are planned for distribution? Or is it sufficient to provide a generic outline of the naming system to be used, for example:
"product name_document name_internal code.PDF"
Thank you.